Effector CD4+ T cells, the cytokines they generate, and GVHD: Something old and something new

James M. Coghill, Stefanie Sarantopoulos, Timothy P. Moran, William J Murphy, Bruce R. Blazar, Jonathan S. Serody

Research output: Contribution to journalArticle

102 Citations (Scopus)

Abstract

GVHD is a syndrome that results from minor and major histocompatibility complex incompatibilities between the donor and recipient. More than 50 years after its initial description, the pathophysiology of GVHD remains poorly understood. Nonetheless, donor T cells have been shown to be critical to the pathophysiology of acute and chronic GVHD, yet precisely how they function remains unclear. The effector mechanisms by which donor T cells mediate tissue inflammation is even less well understood. Identification of several new lineages of CD4+ T cells made in the past decade and their roles in the pathophysiology of T cell-mediated diseases has shed new light on these effector mechanisms. In this review, we summarize the recent descriptions of these T-cell lineages and the current data supporting their role in acute and to a lesser extent chronic GVHD. Investigations into the activity of these new T-cell lineages may provide more rationale approaches to the treatment or prevention of GVHD.

Original languageEnglish (US)
Pages (from-to)3268-3276
Number of pages9
JournalBlood
Volume117
Issue number12
DOIs
StatePublished - Mar 24 2011

Fingerprint

T-cells
Cytokines
T-Lymphocytes
Cell Lineage
Major Histocompatibility Complex
Tissue
Inflammation

ASJC Scopus subject areas

  • Hematology
  • Biochemistry
  • Cell Biology
  • Immunology

Cite this

Coghill, J. M., Sarantopoulos, S., Moran, T. P., Murphy, W. J., Blazar, B. R., & Serody, J. S. (2011). Effector CD4+ T cells, the cytokines they generate, and GVHD: Something old and something new. Blood, 117(12), 3268-3276. https://doi.org/10.1182/blood-2010-12-290403

Effector CD4+ T cells, the cytokines they generate, and GVHD : Something old and something new. / Coghill, James M.; Sarantopoulos, Stefanie; Moran, Timothy P.; Murphy, William J; Blazar, Bruce R.; Serody, Jonathan S.

In: Blood, Vol. 117, No. 12, 24.03.2011, p. 3268-3276.

Research output: Contribution to journalArticle

Coghill, JM, Sarantopoulos, S, Moran, TP, Murphy, WJ, Blazar, BR & Serody, JS 2011, 'Effector CD4+ T cells, the cytokines they generate, and GVHD: Something old and something new', Blood, vol. 117, no. 12, pp. 3268-3276. https://doi.org/10.1182/blood-2010-12-290403
Coghill, James M. ; Sarantopoulos, Stefanie ; Moran, Timothy P. ; Murphy, William J ; Blazar, Bruce R. ; Serody, Jonathan S. / Effector CD4+ T cells, the cytokines they generate, and GVHD : Something old and something new. In: Blood. 2011 ; Vol. 117, No. 12. pp. 3268-3276.
@article{ac1c25ae24754f7b8ad5fdb70e6c4ad2,
title = "Effector CD4+ T cells, the cytokines they generate, and GVHD: Something old and something new",
abstract = "GVHD is a syndrome that results from minor and major histocompatibility complex incompatibilities between the donor and recipient. More than 50 years after its initial description, the pathophysiology of GVHD remains poorly understood. Nonetheless, donor T cells have been shown to be critical to the pathophysiology of acute and chronic GVHD, yet precisely how they function remains unclear. The effector mechanisms by which donor T cells mediate tissue inflammation is even less well understood. Identification of several new lineages of CD4+ T cells made in the past decade and their roles in the pathophysiology of T cell-mediated diseases has shed new light on these effector mechanisms. In this review, we summarize the recent descriptions of these T-cell lineages and the current data supporting their role in acute and to a lesser extent chronic GVHD. Investigations into the activity of these new T-cell lineages may provide more rationale approaches to the treatment or prevention of GVHD.",
author = "Coghill, {James M.} and Stefanie Sarantopoulos and Moran, {Timothy P.} and Murphy, {William J} and Blazar, {Bruce R.} and Serody, {Jonathan S.}",
year = "2011",
month = "3",
day = "24",
doi = "10.1182/blood-2010-12-290403",
language = "English (US)",
volume = "117",
pages = "3268--3276",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "12",

}

TY - JOUR

T1 - Effector CD4+ T cells, the cytokines they generate, and GVHD

T2 - Something old and something new

AU - Coghill, James M.

AU - Sarantopoulos, Stefanie

AU - Moran, Timothy P.

AU - Murphy, William J

AU - Blazar, Bruce R.

AU - Serody, Jonathan S.

PY - 2011/3/24

Y1 - 2011/3/24

N2 - GVHD is a syndrome that results from minor and major histocompatibility complex incompatibilities between the donor and recipient. More than 50 years after its initial description, the pathophysiology of GVHD remains poorly understood. Nonetheless, donor T cells have been shown to be critical to the pathophysiology of acute and chronic GVHD, yet precisely how they function remains unclear. The effector mechanisms by which donor T cells mediate tissue inflammation is even less well understood. Identification of several new lineages of CD4+ T cells made in the past decade and their roles in the pathophysiology of T cell-mediated diseases has shed new light on these effector mechanisms. In this review, we summarize the recent descriptions of these T-cell lineages and the current data supporting their role in acute and to a lesser extent chronic GVHD. Investigations into the activity of these new T-cell lineages may provide more rationale approaches to the treatment or prevention of GVHD.

AB - GVHD is a syndrome that results from minor and major histocompatibility complex incompatibilities between the donor and recipient. More than 50 years after its initial description, the pathophysiology of GVHD remains poorly understood. Nonetheless, donor T cells have been shown to be critical to the pathophysiology of acute and chronic GVHD, yet precisely how they function remains unclear. The effector mechanisms by which donor T cells mediate tissue inflammation is even less well understood. Identification of several new lineages of CD4+ T cells made in the past decade and their roles in the pathophysiology of T cell-mediated diseases has shed new light on these effector mechanisms. In this review, we summarize the recent descriptions of these T-cell lineages and the current data supporting their role in acute and to a lesser extent chronic GVHD. Investigations into the activity of these new T-cell lineages may provide more rationale approaches to the treatment or prevention of GVHD.

UR - http://www.scopus.com/inward/record.url?scp=79953123445&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953123445&partnerID=8YFLogxK

U2 - 10.1182/blood-2010-12-290403

DO - 10.1182/blood-2010-12-290403

M3 - Article

C2 - 21245483

AN - SCOPUS:79953123445

VL - 117

SP - 3268

EP - 3276

JO - Blood

JF - Blood

SN - 0006-4971

IS - 12

ER -